NCT01352962 2026-01-05Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed18 enrolled
NCT02443324 2024-07-31A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerEli Lilly and CompanyPhase 1 Completed175 enrolled 23 charts
NCT03590054 2024-03-22Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesUniversity of California, San FranciscoPhase 1 Completed35 enrolled